NCT06600555

Brief Summary

Surgery is one of the management options for type 2 diabetes in patients with moderate obesity. This is a recent option because it has been part of the recommendations since October 2022. The possible surgical techniques are the same as those for bariatric surgery:

  • Sleeve,
  • Bypass,
  • Gastric band, but the main goal is not weight loss, it is remission of type 2 diabetes. It is called metabolic surgery. The ring technique (gastroplasty) is practiced less and less in France because it is less effective in weight loss and is responsible for major discomfort. Currently, metabolic surgery is one of the recommendations but no study has compared the effectiveness of the techniques with each other. One or other of the techniques can be chosen according to the preferences of the surgeon, the patient, the center, etc. but this choice is not made objectively, in the absence of comparative data. This study would like to follow up on patients for whom metabolic surgery has been proposed by the doctor,. If the surgery is accepted, this study would like to improve knowledge of the effectiveness of the different techniques, and thus demonstrate which metabolic surgery technique is preferred in terms of effectiveness and safety.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable diabetes-mellitus-type-2

Timeline
80mo left

Started Jul 2024

Longer than P75 for not_applicable diabetes-mellitus-type-2

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Jul 2024Dec 2032

Study Start

First participant enrolled

July 3, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 9, 2024

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
8.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2032

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2032

Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

8.4 years

First QC Date

September 9, 2024

Last Update Submit

September 12, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • T2DM remission rate

    HbA1c lower than 6.5% in the absence of antidiabetic treatment, partial, complete, prolonged remission or no remission between the 2 surgical techniques

    1 year after surgery

Study Arms (2)

metabolic surgery with SLEEVE technique

EXPERIMENTAL
Procedure: metabolic surgery with SLEEVE technique

metabolic surgery with BY-PASS technique

EXPERIMENTAL
Procedure: metabolic surgery with BY-PASS technique

Interventions

metabolic surgery with SLEEVE technique

metabolic surgery with SLEEVE technique

metabolic surgery with BY-PASS technique

metabolic surgery with BY-PASS technique

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patient and ≤ 65 years old
  • T2D patient, with individualized glycemic objectives not achieved, despite medical care, in particular diabetological and nutritional, also including adapted physical activity, well conducted according to current good practice recommendations, for at least twelve months
  • BMI between 30 and 34.9 kg/m²
  • patient well informed beforehand about metabolic surgery and the study
  • medical assessment of an acceptable surgical risk
  • patient affiliated to or beneficiary of a social security system
  • patient having freely signed the written informed consent

You may not qualify if:

  • severe cognitive or mental disorders
  • severe and unstabilized eating behavior disorders
  • dependence on alcohol and licit and illicit psychoactive substances
  • illnesses endangering life in the short and medium term
  • contraindications to general anesthesia
  • absence of identified prior medical care and foreseeable inability of the patient to participate in lifelong medical monitoring
  • history of bariatric surgery
  • pregnant or breastfeeding woman, or having a very long-term pregnancy plan short term (\< 2 years)
  • adult patient under guardianship or curatorship
  • patient deprived of liberty or under judicial decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medipole Lyon Villeurbanne

Villeurbanne, 69100, France

RECRUITING

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Obesity

Interventions

Bariatric Surgery

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

BariatricsObesity ManagementTherapeuticsSurgical Procedures, Operative

Central Study Contacts

laetitia paradisi, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 9, 2024

First Posted

September 19, 2024

Study Start

July 3, 2024

Primary Completion (Estimated)

December 1, 2032

Study Completion (Estimated)

December 1, 2032

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations